Product Name:

Chk1-pS317


Product Number:

ab-pk580

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Checkpoint protein-serine kinase 1

Target Alias: CHEK1; CCDS8459.1; ENSG00000149554

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK578

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: S317

Protein UniProt: O14757

Protein SigNET: O14757

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human Chk1 (CHEK1) sequence peptide Cat. No.: PE-04AJW95

Antibody Immunogen Sequence: YSS(pS)QPE(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues Y314 to E320; In the C-terminal half of the kinase after the catalytic domain

Production Method: Corresponds to amino acid residues Y314 to E320; In the C-terminal half of the kinase after the catalytic domain

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Very strong immunoreactivity with immunogen peptide on dot blots.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 54-58 kDa.

Antibody Specificity: Very high

Antibody Cross Reactivity: No significant cross-reactive proteins detected in HeLa cells and in sea star oocytes.

Scientific Background: Chk1 (CHEK1) is a protein-serine/threonine kinase of the CAMK group and CAMKL family. It is required for checkpoint-mediated cell cycle arrest. It appears to be a tumour suppressor protein (TSP). The active form of the protein kinase normally acts to inhibit tumour cell proliferation. It activates DNA repair (i.e. homologous recombination) by phosphorylating RAD51 or FANCE in response to the presence of damage or unreplicated DNA. It regulates cell cycle progression via several mechanisms: 1) phosphorylation of certain proteins such as CDC25A, CDC25B and CDC25C, promoting their degradation; 2) phosphorylation and activation of p53; 3) phosphorylation and inactivation of TLK1, which consequently prevents TLK1-dependent phosphorylation of chromatin assembly factor ASF1A; 4) phosphorylation of histones and regulating transcription of genes involved in cell-cycle progression regulation; 5) phosphorylation of RB1 to promote its interaction with E2F transcription factors and subsequent cell cycle arrest. It is nhibited by phosphorylation at S280. S345A mutation of Chk1 leads to reduced phosphorylation and impaired activation to nuclear retention after checkpoint activation. Mutations at 372, 376, and 379 amino acids lead to misfolding and induced binding with ubiquitin.